<code id='C31D4316AA'></code><style id='C31D4316AA'></style>
    • <acronym id='C31D4316AA'></acronym>
      <center id='C31D4316AA'><center id='C31D4316AA'><tfoot id='C31D4316AA'></tfoot></center><abbr id='C31D4316AA'><dir id='C31D4316AA'><tfoot id='C31D4316AA'></tfoot><noframes id='C31D4316AA'>

    • <optgroup id='C31D4316AA'><strike id='C31D4316AA'><sup id='C31D4316AA'></sup></strike><code id='C31D4316AA'></code></optgroup>
        1. <b id='C31D4316AA'><label id='C31D4316AA'><select id='C31D4316AA'><dt id='C31D4316AA'><span id='C31D4316AA'></span></dt></select></label></b><u id='C31D4316AA'></u>
          <i id='C31D4316AA'><strike id='C31D4316AA'><tt id='C31D4316AA'><pre id='C31D4316AA'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:33
          An interface with a wire frame human on the center left, a human brain on the top right, a microscope on the bottom left, and some codes on both sides — coverage from STAT
          Adobe

          If the past year was prelude, the U.S. government in 2024 is poised to re-write the rules surrounding the use of artificial intelligence in health care.

          Just in the past few months, President Joe Biden ordered a sweeping crackdown on AI by federal health agencies; members of Congress promised to step up oversight and pass new legislation; and many AI experts, from within industry and outside of it, sounded alarms about the urgent need for standards.

          advertisement

          The heightened scrutiny is driven by rapid advances of generative AI tools such as ChatGPT. But makers of all kinds of predictive models may, for the first time, be required to explain how their systems were developed and tested — and prove that they are safe, reliable, and fair.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Disappointing trial forces Pfizer to pivot on obesity medicine plans
          Disappointing trial forces Pfizer to pivot on obesity medicine plans

          MarkLennihan/APPfizeronFridaysaiditwasstoppingdevelopmentofatwice-dailyoralobesitymedicationafteranu

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

          Hevolution'sexecutiveteamincludes,fromleft,SophiaPathai,HayaBintKhaledBinBandarAlSaud,MehmoodKhan,an